These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7797949)

  • 1. The predictive value of T cell function in vitro and pre-AIDS zidovudine use for survival after AIDS diagnosis in a cohort of homosexual men in Amsterdam.
    Bindels PJ; Krol A; Roos M; Veenstra J; van den Hoek JA; Miedema F; Coutinho RA
    J Infect Dis; 1995 Jul; 172(1):97-104. PubMed ID: 7797949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.
    Keet IP; Krol A; Koot M; Roos MT; de Wolf F; Miedema F; Coutinho RA
    AIDS; 1994 Nov; 8(11):1577-83. PubMed ID: 7848594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS.
    Strathdee SA; Frank JW; McLaughlin J; Leblanc M; Major C; O'Shaughnessy MV; Read SE
    J Infect Dis; 1995 Nov; 172(5):1375-9. PubMed ID: 7594682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.
    Graham NM; Zeger SL; Kuo V; Jacobson LP; Vermund SH; Phair JP; Detels R; Rinaldo CR; Saah AJ
    J Acquir Immune Defic Syndr (1988); 1991; 4(3):267-76. PubMed ID: 1671411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
    Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
    AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men.
    Burcham J; Marmor M; Dubin N; Tindall B; Cooper DA; Berry G; Penny R
    AIDS; 1991 Apr; 5(4):365-72. PubMed ID: 1676279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
    Giorgi JV; Ho HN; Hirji K; Chou CC; Hultin LE; O'Rourke S; Park L; Margolick JB; Ferbas J; Phair JP
    J Infect Dis; 1994 Oct; 170(4):775-81. PubMed ID: 7930717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
    Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.
    Vella S; Giuliano M; Floridia M; Chiesi A; Tomino C; Seeber A; Barcherini S; Bucciardini R; Mariotti S
    AIDS; 1995 Jan; 9(1):51-6. PubMed ID: 7893441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival of patients with zidovudine resistant HIV].
    Gøtzsche PC; Nielsen C; Gerstoft J; Nielsen CM; Vestergaard BF
    Ugeskr Laeger; 1994 Jan; 156(2):185-6. PubMed ID: 7905217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
    Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
    Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
    Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
    Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.
    Hendriks JC; Satten GA; van Ameijden EJ; van Druten HA; Coutinho RA; van Griensven GJ
    AIDS; 1998 Aug; 12(12):1537-44. PubMed ID: 9727576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.
    Stein DS; Graham NM; Park LP; Hoover DR; Phair JP; Detels R; Ho M; Saah AJ
    Ann Intern Med; 1994 Jul; 121(2):100-8. PubMed ID: 8017721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.
    Graham NM; Piantadosi S; Park LP; Phair JP; Rinaldo CR; Fahey JL
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1258-66. PubMed ID: 7901384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.
    Holmberg SD; Conley LJ; Buchbinder SP; Judson FN; Bush TJ; Katz MH; Penley KA; Hershow RC
    AIDS; 1993 May; 7(5):699-704. PubMed ID: 8318177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
    Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
    Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA
    AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.